Regarding GPx3, it can be considered a novel tumor-suppressor gene [232,233] because hypermethylation is detected with down-regulation of GPx3 in tumor patients with Barrett’s esophagus [234], prostate cancer [235], and endometrial adenocarcinoma [232,236]. This evidence concerns the gene GPX3 and Familial prostate cancer.